Brand-name GLP-1 medications like Ozempic and Mounjaro can be prohibitively expensive, costing up to $1,500$2,000 per month due to insurance markups and brand premiums
The satiety cascade, first proposed in the 1980s and modified throughout, indicates that satiation and satiety are governed by the interplay of metabolic, cognitive, and sensory factors, which are interconnected components [31,33,34]
During dose escalation The first few weeks on any GLP-1 medication are the riskiest for side effects
Appetite suppression strengthens and metabolic improvements begin
MT-II is used when broader melanocortin receptor activation including central effects is the research objective